Dyne Therapeutics, Inc.
NasdaqGS:DYN
$ 23.70
$-1.28 (-5.12%)
$ 23.70
$-1.28 (-5.12%)
End-of-day quote: 04/25/2024

DYN: Global investment alternatives & competitors

Competitors

Ticker Price Forecast 1Y Forecast 2Y Market Cap Div Yld Growth Rate
ENXTPA:SAN
Sanofi
91.62 21.11% 40.45% 109,506.23 4.29% 8.19%
TSE:4568
Daiichi Sankyo Company
4766.00 0% 0% 9,606,688.48 1.27% 0%
TSE:4502
Takeda Pharmaceutical Company
4090.00 0% 0% 6,383,951.56 4.55% 0%
NasdaqGS:MRNA
Moderna
106.18 -,114.04% -,109.69% 38,827.82 0% 0%
NasdaqGS:BIIB
Biogen
202.46 -3.23% 13.94% 29,361.43 0% -10.89%
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
143.71 0% 0% 18,260.95 0% 0%
NasdaqGS:BMRN
BioMarin Pharmaceutical
82.17 113.18% 183.08% 17,307.48 0% 32.46%
NasdaqGS:SRPT
Sarepta Therapeutics
127.39 0% 0% 10,851.56 0% 0%
NasdaqGS:IONS
Ionis Pharmaceuticals
41.84 -,150.35% -,143.74% 6,374.47 0% 0%
TSE:4516
Nippon Shinyaku
4307.00 0% 0% 283,218.43 2.89% 0%
NasdaqGS:DCPH
Deciphera Pharmaceuticals
14.18 0% 0% 1,286.34 0% 0%
NasdaqGM:WVE
Wave Life Sciences
4.74 0% 0% 768.25 0% 0%
NasdaqGS:STOK
Stoke Therapeutics
11.69 0% 0% 624.9 0% 0%
NasdaqGS:ABUS
Arbutus Biopharma
2.72 0% 0% 474.02 0% 0%
NasdaqGM:FULC
Fulcrum Therapeutics
7.13 0% 0% 425.13 0% 0%
ASX:PYC
PYC Therapeutics
0.09 0% 0% 294.9 0% 0%